Patent · US Active

Compounds and uses thereof

US7425556B2 · kind B2 · utility

8Cited by
26References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2006
Grant dateSep 16, 2008
Priority date
Expiry dateDec 18, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to novel compounds having the structural formula I below:and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.